Hepatitis C Management
Hepatitis C Monograph
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: February 6, 2004
Renewal Date: June 12, 2009
Expiration Date: June 12, 2010
Estimated Time of Completion: 2 hours and 15 minutes
Description
The management
of hepatitis C virus (HCV) continues to evolve. HCV is a common
chronic viral infection world-wide. In North America more than 5%
of certain groups are infected. Currently, HCV infection is responsible
for an estimated 8,000 to 10,000 deaths annually in the U.S., and
is expected to triple in the next 10 to 20 years. In today's fast-paced
environment, health care professionals are multi-tasking and struggling
to stay current on the latest developments in Hepatitis C.
The monograph contains the most current information to manage the HCV patient. The monograph was created by renowned experts, and includes key strategies and recommendations.
Objectives
At the conclusion of this activity, the participant will be able to:
- Recognize risk factors, natural history, and treatment of hepatitis C.
- Optimize patient selection for treatment.
- Optimize diagnostic testing, including the role of liver biopsy.
- Maximize patient compliance with therapy.
Target Audience
Directed to gastroenterologists, infectious disease physicians, infectious disease and gastroenterology nurse practitioners, infection control nurses, physician assistants, and managed care organizations.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
William D. Carey, MD
Department of Gastroenterology & Hepatology
Cleveland Clinic
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio
Author / Faculty
| Lennox Jeffers, MD Chief, Hepatology Section VA Medical Center Associate Chief Center for Liver Disease Professor of Medicine School of Medicine University of Miami Miami, Florida |
Marcelo Kugelmas, MD South Denver Gastroenterology, P.C. Denver, Colorado |
| Thomas Layden, MD Professor of Medicine Head Department of Medicine University Illinois Chicago Chicago, Illinois
|
Guy Neff, MD, MBA Associate Professor of Medicine Medical Director of Liver Transplant University of Cincinnati Cincinnati, Ohio |
| Glenn Treisman, MD, PhD Professor Psychiatry & Behavioral Sciences and Internal Medicine Johns Hopkins University, School of Medicine Baltimore, Maryland |
Carla Viscomi, RN, BSN Department of Gastroenterology & Hepatology MetroHealth System Department of Gastroenterology & Hepatology Cleveland Clinic Cleveland, Ohio |
| Zobair Younossi, MD, MPH Executive Director of Research, Inova Health System Executive Director, Center for Liver Diseases Professor of Medicine, VCU-Inova Campus Affiliate Professor of Biomedical Sciences George Mason University Falls Church, Virginia |
Nizar Zein, MD Chief, Section of Hepatobiliary Disease Medical Director, Liver Transplantation Department of Gastroenterology & Hepatology Cleveland Clinic Associate Professor of Medicine Cleveland Clinic Lerner College of Medicine Cleveland, Ohio |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Marcelo Kugelmas, MD | ||
| Grant/Research Support Consultant Speakers' Bureau |
Amgen, Schering-Plough Schering-Plough Amgen, Gilead, GlaxoSmithKline, Schering-Plough |
|
| Thomas Layden, MD | ||
| Grant/Research Support Consultant |
Roche Laboratories, Celera Roche Laboratories, Schering-Plough |
|
| Zobair Younossi, MD, MPH | ||
| Grant/Research Support |
Amgen, Roche Laboratories, Vertex, Pfizer, Schering-Plough, Biolex, Human Genome Sciences, Wyeth, Gilead Sciences |
|
| Nizar Zein, MD | ||
| Grant/Research Support |
InterMune, Roche Laboratories |
|
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
William D. Carey, MD
Lennox Jeffers, MD
Guy Neff, MD, MBA
Glenn Treisman, MD, PhD
Carla Viscomi, RN, BSN
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges an educational grant for support of this activity from:
Roche
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and UNITECH Communications®.
